Skip Ribbon Commands
Skip to main content

Regulations

:

10.47.07.02, .04, and .05 Prescription Drug Monitoring Program (PHS)

Reg Name

10.47.07.02, .04, and .05  Prescription Drug Monitoring Program (PHS)

Synopsis

​The purpose of this action is to enable the Maryland Prescription Drug Monitoring Program (PDMP) to implement recent expansion of the requirements and authorities of the PDMP to support the safe and effective use of controlled dangerous substance prescription in Maryland. These guidelines are being promulgated in accordance with H.B. 25, Ch. 531, Acts of 2019, Public Health — Prescription Drug Monitoring Program — Revisions, and H.B. 466, Ch. 364, Acts of 2019, Prescription Drug Monitoring Program — Program Evaluation.​

Compliance

​N/A

Documents

10.47.07.02, .04, .05.docx10.47.07.02, .04, .05.docx Maryland Register

10.47.07.02, .04, .05.docx10.47.07.02, .04, .05.docx FINAL AAP text

Printed in Maryland Register

1/17/2020

End of Comment Period

2/18/2020

FINAL Printed

5/8/2020

Type of Adoption

FINAL AAP

Effective Date

5/18/2020

Attachments

Content Type: Item
Created at 1/21/2020 9:21 AM by System Account
Last modified at 5/9/2020 11:06 AM by System Account